diazoxide has been researched along with Infant, Small for Gestational Age in 9 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diazoxide is commonly used in the treatment of neonatal hyperinsulinism." | 7.74 | Development of pulmonary hypertension in an infant treated with diazoxide. ( Caldwell, RL; Eugster, EA; Hoover, WC; Nebesio, TD; Nitu, ME, 2007) |
| "Diazoxide is commonly used in the treatment of neonatal hyperinsulinism." | 3.74 | Development of pulmonary hypertension in an infant treated with diazoxide. ( Caldwell, RL; Eugster, EA; Hoover, WC; Nebesio, TD; Nitu, ME, 2007) |
| "02) were significantly lower in the diazoxide group, with no adverse effects attributed to the drug." | 2.87 | Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. ( Attri, SV; Balachandran, B; Mukhopadhyay, K; Sachdeva, N; Walia, R, 2018) |
| "Current concepts in the conduct of preterm labor and management of delivery of the premature infant are reviewed." | 2.36 | Contemporary management and conduct of preterm labor and delivery: a review. ( Guilliams, S; Held, B, 1979) |
| "Diazoxide was initiated at 3 mg/kg/day at a median age of 10 days." | 1.72 | Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia. ( Chandran, S; Mei Chien, C; R, PR; Rajadurai, VS; Saffari, SE; Yap, F, 2022) |
| "Hyperinsulinism was diagnosed as hypoglycemia concomitant with high serum insulin in babies requiring >6 mg/kg/min intravenous glucose and THI as hyperinsulinism without maternal diabetes or genetic disorders." | 1.42 | Fetal Erythroblastosis May Be an Indicator of Neonatal Transient Hyperinsulinism. ( Hata, D; Iki, Y; Katayama, T; Kawai, M; Mizumoto, H; Yamashita, S, 2015) |
| "Treatment with diazoxide and chlorothiazide was effective." | 1.31 | The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. ( Barbetti, F; Brusgaard, K; Buettger, C; Christesen, HB; Cuesta-Munoz, A; Hansen, T; Jacobsen, BB; Magnuson, MA; Massa, O; Matschinsky, FM; Odili, S; Shiota, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, S | 2 |
| R, PR | 1 |
| Mei Chien, C | 1 |
| Saffari, SE | 1 |
| Rajadurai, VS | 2 |
| Yap, F | 1 |
| Balachandran, B | 1 |
| Mukhopadhyay, K | 1 |
| Sachdeva, N | 1 |
| Walia, R | 1 |
| Attri, SV | 1 |
| Chong, JH | 1 |
| Agarwal, P | 1 |
| Blanco, M | 1 |
| Khan, O | 1 |
| Stanley, K | 1 |
| Hageman, JR | 1 |
| Greeley, SA | 1 |
| Mizumoto, H | 1 |
| Iki, Y | 1 |
| Yamashita, S | 1 |
| Kawai, M | 1 |
| Katayama, T | 1 |
| Hata, D | 1 |
| Arya, VB | 1 |
| Flanagan, SE | 1 |
| Kumaran, A | 1 |
| Shield, JP | 1 |
| Ellard, S | 1 |
| Hussain, K | 1 |
| Kapoor, RR | 1 |
| Nebesio, TD | 1 |
| Hoover, WC | 1 |
| Caldwell, RL | 1 |
| Nitu, ME | 1 |
| Eugster, EA | 1 |
| Christesen, HB | 1 |
| Jacobsen, BB | 1 |
| Odili, S | 1 |
| Buettger, C | 1 |
| Cuesta-Munoz, A | 1 |
| Hansen, T | 1 |
| Brusgaard, K | 1 |
| Massa, O | 1 |
| Magnuson, MA | 1 |
| Shiota, C | 1 |
| Matschinsky, FM | 1 |
| Barbetti, F | 1 |
| Guilliams, S | 1 |
| Held, B | 1 |
1 review available for diazoxide and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Contemporary management and conduct of preterm labor and delivery: a review.
Topics: Adrenal Cortex Hormones; Bed Rest; Diazoxide; Female; Fetal Distress; Humans; Infant, Newborn; Infan | 1979 |
1 trial available for diazoxide and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects.
Topics: Congenital Hyperinsulinism; Diazoxide; Female; Humans; Infant, Newborn; Infant, Small for Gestationa | 2018 |
7 other studies available for diazoxide and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Female; Gestational Age; Humans; Infant; Infant, Newbo | 2022 |
Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate.
Topics: Blood Glucose; Diazoxide; Female; Humans; Hyperinsulinism; Hypoglycemia; Infant, Newborn; Infant, Sm | 2013 |
Hyperinsulinism in a neonate.
Topics: Blood Glucose; Diagnosis, Differential; Diazoxide; Humans; Hyperinsulinism; Infant, Newborn; Infant, | 2014 |
Fetal Erythroblastosis May Be an Indicator of Neonatal Transient Hyperinsulinism.
Topics: Apgar Score; Birth Weight; Diazoxide; Erythroblastosis, Fetal; Erythrocyte Count; Female; Gestationa | 2015 |
Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age.
Topics: Antihypertensive Agents; ATP-Binding Cassette Transporters; Blood Glucose; Diazoxide; Gestational Ag | 2013 |
Development of pulmonary hypertension in an infant treated with diazoxide.
Topics: Diazoxide; Female; Humans; Hyperinsulinism; Hypertension, Pulmonary; Hypoglycemia; Hypoglycemic Agen | 2007 |
The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.
Topics: Adolescent; Allosteric Regulation; Diabetes Mellitus; Diazoxide; Enzyme Activation; Glucokinase; Glu | 2002 |